chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Prior to his second vaccine he had gone 6 weeks without a restraint.    Within an 1 to 1.5 hours of receiving the vaccine he became physically aggressive requiring restraint.   Within the week following the vaccine he was physically restrained due to aggression easily 10-15 times.  During one incident he hit his mother in the head with a hard plastic rod.  He has been physically aggressive but not using an item like a weapon like that.  He had multiple restraints/incidents per day for about 1.5-2 weeks which is unusual for him.    We called crisis multiple times.  We considered psychiatric hospitalization but at first we couldn't find a hospital that would take him because of the potty training issue.  When we finally did find a hospital that would take him the wait was 3-4 weeks for a bed so in consultation with his psychiatrist decided to add clonidine to try to stabilize him.  His primary neurologist Dr. thinks he had an inflammatory response to the vaccine.  His secondary neurologist Dr.  wonders if he was having severe headaches and is recommending a medication change.   His allergist/immunologist from  doesn't think it was an allergic reaction to the shot but stated given the timing a reaction to the vaccine can't be ruled out.  His developmental pediatrician from Dr.  is wondering if his autism impacted his ability to report what the symptoms/reactionw was.   As of 2/21/2022 he is still having multiple restraints per week, though the frequency and length have decreased.  He is still not back to baseline.
my left hand went numb a little beyond my wrist and then my left foot started feeling numb too and my fingers are still numb and the tops of my toes feel numb.; toes also sting a little bit at times; nervous about my side effect; This is a spontaneous report from a contactable consumer (patient) via Pfizer Medical Information department.  A 50-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 21Mar2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications was not reported. On 21Mar2021, about 30 minutes after receiving the vaccine, which they gave it to her in her left arm, her left hand went numb a little beyond her wrist and that lasted about 5 hours and then her left foot started feeling numb too. On 22Mar2021 (this morning) the tops of her fingers were still numb, and the tops of her toes feel numb. The tops of her toes also sting a little bit at times (start date: Mar2021). She was working from home on 2Mar2021 (today) and when she used her left hand the numbness seemed to get worse. She stated that she should rather talk to someone about her medical situation first and then she can come back to Pfizer, but she really needed to speak to someone because she was little nervous about her side effect (start date: Mar2021). Events assessed as non-serious by reporter. The clinical outcome of 'my left hand went numb a little beyond my wrist and then my left foot started feeling numb too and my fingers are still numb, and the tops of my toes feel numb' was not recovered and for rest all the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
NOse bleed that would not stop, weakness in body, leg pain, feeling of stiffness in back.
DEEP BONE PAIN IN LEGS; CHILLS; This spontaneous report received from a consumer concerned a 20 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 30-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 30-JUL-2021, the subject experienced deep bone pain in legs. On 30-JUL-2021, the subject experienced chills. Treatment medications (dates unspecified) included paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from chills, and had not recovered from deep bone pain in legs. This report was non-serious.
Patient said she had  redness/rash on upper chest-she couldn't remember exactly what day it started--she thought within 6 days of vaccination
Vaccine went into 2-8 Celsius thaw state on or about 24 Dec 2021 and administered on 11 Mar 2022; Vaccine went into 2-8 Celsius thaw state on or about 24 Dec 2021 and administered on 11 Mar 2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24 Dec 2021 and administered on 11 Mar 2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24 Dec 2021 and administered on 11 Mar 2022) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2022 at 2:03 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 11-Mar-2022 at 2:03 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24 Dec 2021 and administered on 11 Mar 2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24 Dec 2021 and administered on 11 Mar 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24 Dec 2021 and administered on 11 Mar 2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24 Dec 2021 and administered on 11 Mar 2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Prescriptions, over the counter medications, dietary supplements or herbal remedies being taken at time of vaccination  or at the time of the adverse event were reported as unknown. Other vaccines given on the same day as Moderna COVID-19 vaccine and other vaccines received within one month prior to any dose of Moderna COVID-19 vaccine were reported as unknown. It was reported that the vaccine went into 2-8 C thaw state on or about 24 Dec 2021 and the patient received booster dose  past its 30-days expiry date on 11 Mar 2022 at 14.03.34. No treatment information was reported.
I went into a local pharmacy to ge the new Pfizer Bivalent vaccine at 10:30 am It was injected into my body and I went home. By 12 noon on the same day, my pharmacist called me in tears, stating that the tech in charge of the vaccines, drew the wrong medication and injected it into me. Upon further discussion I discovered that more individuals were also injected with the wrong medication. I am furious and am not sure how or to who to report this. I have been told that I can not now get the correct vaccination for 2 months. I exchanged a few emails with our state CDC office but they do not seem to be interested in this incident. Again, I am furious. This was injection into my body!!!! Age 72
Stroke; I am not feeling well; This is a spontaneous report from a contactable consumer (patient herself). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, manufacturer: Unspecified; Lot number; NDC number; UPC number; Expiry Date: Unknown) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient stated that she received the first dose and is scheduled to get the second dose, but she had a stroke and is now on blood thinners. She stated that she had the stroke after receiving the first dose of the COVID-19 vaccine. She wanted to know if there was any contraindication for getting the second dose of the vaccine while on blood thinners and also patient reported that she is not feeling well on an unknown date. She works in a hospital and she involve with people every day with covid but she is not a doctor, nurse but she is working in emergency. Therapeutic measures were taken as a result of stroke with blood thinner. The outcome of the events was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
This solicited report was received from a pharmacist via a company representative referring to a patient of unknown age and gender enrolled in an unspecified patient support program. The patient's medical history and concurrent conditions were not reported. The pharmacist reported that the patient was vaccinated with ZOSTAVAX 19400 PFU, on unspecified dates, reported as "3 times in the last 3 years" (strength, route of administration, dose, lot number and expiration date were not reported). The patient's concomitant medications were not reported. No adverse effects were reported and no product quality complaint was involved. Additional information has been requested.
My period is late. Absolute no chance I'm pregnant. My PMS symptoms are also exaggerated.
her arm is sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 20Feb2021 (Batch/Lot number: unknown) as dose 1, single and administration date 21Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "her arm is sore".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I got the vaccine on Tuesday. That night, I had some slight aches and was warm, but nothing awful. The next day, I was just a bit warm. I exercised on Thursday morning because I felt better (stand up paddling). Then the rest of the day, I was very tired and then Friday and Saturday and Sunday, I was very dizzy, foggy, fatigued, no mental clarity, difficult to hold a conversation and answer questions, no focus. Today, Monday, I still feel like I have a brain fog and am talking very slowly. No focus. Conversations feel tiring.
may have been exposed to covid-19 and is symptomatic; may have been exposed to covid-19 and is symptomatic; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team for a Pfizer sponsored program (159558).  A 65 year-old female patient received bnt162b2 (BNT162B2), administration date Dec2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2021, outcome "unknown" and all described as "may have been exposed to covid-19 and is symptomatic".  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on available information a contributory role of BNT162B2 to the reported events Covid-19 and Drug ineffective cannot be totally excluded as efficacy of a drug varies from individual to individual depending upon the immune status. As with any vaccine, vaccination with BNT162B2 may not protect all vaccine recipients, so the expectedness of covid-19 and drug ineffective is : expected. The case will be reassessed further upon receipt of additional information.
Shortly after the injection I had tingling in my left hand which I thought was normal. Now two days since the injection and I still have tingling in my left hand and fingers.
12/09/2003 @ 10:00: Vaccines given.  12/09/03 @ 15:00: Pt's grandmother called to report aht child have been crying for greater than 2 hours.  Stated child did not have fever.  Infant Tylenol had been given at 14:45.  Nurse to check with pt in 1 hour 12/09/03 @ 16:00: Telephone call, grandmother stated parents took child to ER after observing a "small seizure".  12/10/03@ 07:45: Telephone call, grandmother stated child is doing better-was not admitted to hospital.  Was advised by ER staff to continued prescribing Tylenol.
Vesicular rash, induration, erythema, cellulitis 1 1/2 weeks after Varivax and Prevnar given.
Rash noted on trunk and abd, red, flat, no itchy reported on fever reported. Mother stated rash 2 days after immunization.
This patient had dizziness, blurred vision, and tingling in his arms on the first dose. He presented for his second dose which was administered and we had him wait for 30 minutes just to make sure he did not have an allergic reaction. He ate with this vaccination (unlike the first) and felt fine afterwards.  The vaccination was administered at 2:56 and he presented back to the pharmacy at 6:30 complaining of itching all over. He was given 50 mg of Benadryl at 6:34 and his BP was 151/116 with a pulse of 78. At 6:43 his BP was 137/96 with a pulse of 78. At 6:50 his BP was 118/96 with a a pulse of 73 and at 6:55 it was 120/95 with a pulse of 75. He was better at this point and went back to work.
Headache, Myalgia, UrticariaPruritus, NauseaVomiting, prickling sensation off/on throughtout body, swollen lymph nodes, fatigue Narrative:
Patient was sitting in chair on mother's lap in waiting room, post flu vaccine administration, when patient slid off mother's lap and onto the floor. Questionable brief loss of consciousness. When RN arrived, patient was awake and alert. Patient was initially assessed for injuries in waiting room, and found to have none. Patient was brought back into an exam room where vitals were completed, along with an assessment by Dr. Patient was found to be free of injury, awake and alert. Patient was then sent home with mother.
This spontaneous report as received from an unspecified reporter refers to a patient of unknown age and gender. On 10-FEB-2015 the patient was vaccinated with M-M-R II (route, dose, frequency and lot # not reported) which underwent an excursion (on an unspecified date). This is one of several reports from the same source. Additional information has been requested.
pt recv vax;lower limb girdle ache followed w/in 24 hr upper limb girdle aches;awakened fr sleep;ASA, codeine; no tenderness or weakness;fever to 102R; chills & mild conjunctivitis but disappeared on 28may95;
Eye irritation; This spontaneous case was reported by a consumer and describes the occurrence of EYE IRRITATION (Eye irritation) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EYE IRRITATION (Eye irritation). At the time of the report, EYE IRRITATION (Eye irritation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Body aches; fever; sleepiness; headaches; vivid dreams; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 06Aug2021 at 09:30 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history included multiple personality disorder, depression and COVID-19. The patient was allergic to latex and opiates. Prior to the vaccination, the patient was diagnosed with COVID-19.  The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Jul2021 at 09:30 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Aug2021 at 16:00, the patient experienced body aches, fever, sleepiness, headaches and vivid dreams. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches, fever, sleepiness, headaches and vivid dreams were recovering at the time of this report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Pt recvd 3 doses of Engerix-B 15JAN91, 16FEB91 & 16JUL91; reporter indicated due to neg HBSAB titer result, 4th dose of Engerix-B required 29SEP91;
On 1/12/01, telephone call received from daughter of client who relayed that her mom was transported to health dept for a flu shot on 1/2/01 by personnel from adult care facility at 13:00. When client awoke in the AM of 1/3/01, she was unable to walk, write, had swallowing difficulties and slurred speech. She was taken by the facility's staff to ER at 16:00 on 1/3/01. She was admitted to the hospital where testing was done but daughter unsure of specific tests. Daughter stated physicians said it wasn't a stroke. She is slowly recovering.
This spontaneous report as received from a pharmacist refers to a 92 year old female patient. Patients current condition included allergy to ACE inhibitors and fish. On 09-DEC-2013, in a nursing home, the patient was vaccinated with ZOSTAVAX (lot number, expiry date and dose were not reported) dose 1, subcutaneously after having shingles the previous week (December 2013). No concomitant medications were reported). On 16-DEC-2013, 8 days after onset of therapy the patient experienced swelling of tongue (medically significant). The patient was treated with BENADRYL and epinephrine in separate arms (It is unspecified if the BENADRYL and epinephrine have been administered). The outcome of swelling of tongue was reported as not recovered/not resolved. The causality of the event in relation to ZOSTAVAX was not reported. Additional information has been requested.
Dizzy; short term memory sucks and it's frustrating; Can't see well; Fibromyalgia; bone pain; Neuropathy; Feeling aches in the body; Bells palsy-paralysis on the left side of the face/ pressure on the left side of the face and neck; headache; Ringing in the ears; Pressure in the ears; A spontaneous report was received from consumer concerning a 41-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pressure in ears/ear discomfort, ringing in ears/tinnitus,  pressure on the left side of the face and neck which was found to be Bell's Palsy/facial paralysis, Headache, neuropathy peripheral, fibromyalgia, memory impairment, couldn't see well/visual decrease, feeling aches in the body/myalgia, and dizziness.  The patient's medical history included neuropathy and fibromyalgia and past cancer. No relevant concomitant medications were reported.   On 03 Feb 2021, the patient received the first of two doses of mRNA-1273 (Lot number: 028L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 24FEB2021 the patient began experiencing pressure and a ringing in the ears and then started like a pressure on the left side of the face and neck. On 25FEB2021, the patient started having a  headache and on 26FEB2021 the paralysis on the left side of the face began. The patient said that it worsened, couldn't eat, couldn't speak, and went to the hospital. The patient said that they had a CT Scan, and the result was that it wasn't a stroke. Vitals were taken and blood work came back normal.  The conclusion was Bell's Palsy.  The patient stated that they couldn't see well and were dizzy.  The patient said that they were experiencing fibromyalgia and neuropathy that they had when they had cancer.  The patient also mentioned that they were experiencing some bone pain and that their short term memory was not good and was frustrating.    Treatment of these events were not reported.  The outcome of the events, ear discomfort, tinnitus, facial paralysis, headache, neuropathy peripheral, fibromyalgia, memory impairment, visual decrease, myalgia and dizziness were considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  The patient's medical history of neuropathy, fibromyalgia and past history of cancer remains the contributing factors. Further information has been requested.
tiredness; This is a spontaneous report from a contactable consumer (patient), based on the information received by Pfizer from  (manufacturer control number: EC-2020-084563), for BNT162B2. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 at single dose for covid, lenvatinib mesilate (LENVIMA), via an unspecified route of administration from 16Nov2020 to an unspecified date at 12 mg, daily for hepatocellular carcinoma (HCC) C22. The patient's medical history included headache. Concomitant medications were not reported. Patient reported headache and some tiredness since taking lenvatinib mesilate but also thought that her tiredness was attributed to her receiving COVID vaccine. The patient experienced tiredness on 19Jan2021 with outcome of unknown. Action taken for lenvatinib mesylate was unknown.   No follow-up attempts are possible, information about batch number cannot be obtained.
Started w/ itching of the eyes, sudden cough. Within an hour, swelling of the eyes and lips, difficulty breathing, hives,inability to swallow, confusion, headache, runny eyes, blood red sclera. Took Benadryl and prayed. Could not seek medical attention because I have no health insurance. Could not breath at all while lying down.
Patient had a vaso-vagal response as described by the immunizing nurse.  Symptoms included decreased BP, confusion, pale appearance
Moderate swelling on right side leg from thigh to knee; and mild swelling from knee to foot. Slight red rash on thigh.
Rash noticed on arms, legs, and trunk beginning on 7/1.  Rash does not itch and is not painful but is getting larger.  Patient started CELEBREX at the same time.